Differential expression analysis of balding and nonbalding dermal papilla microRNAs in male pattern baldness with a microRNA amplification profiling method

British Journal of Dermatology

Volumn 166, Issue 5, 2012, Pages 1010-1016

  Goodarzi, H R ^a   Abbasi, A ^b   Saffari, M ^c   Fazelzadeh Haghighi, M ^a   Tabei, M B ^a   Noori Daloii, M R ^c  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Hair Transplant Surgery Unit   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 106A; MICRORNA 125B; MICRORNA 221; MICRORNA 410; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE AMPLIFICATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GENETIC SCREENING; HAIR FOLLICLE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MALE TYPE ALOPECIA; MOLECULAR CLONING; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SKIN CELL; STATISTICAL SIGNIFICANCE; UPREGULATION;

ALOPECIA; CLONE CELLS; DNA, COMPLEMENTARY; GENE EXPRESSION; GENE LIBRARY; HAIR FOLLICLE; HUMANS; MALE; MICRORNAS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UP-REGULATION;

EID: 84860339812     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10675.x     Document Type: Article

References (50)

1. Stough D, Stenn K, Haber R, et al. Psychological effect, pathophysiology, and management of androgenetic alopecia in men. Mayo Clin Proc 2005; 80: 1316-22. (Pubitemid 41395965)
2. Pang Y, Young CY, Yuan H,. MicroRNAs and prostate cancer. Acta Biochim Biophys Sin (Shanghai) 2010; 42: 363-9.
3. Oh BR, Kim SJ, Moon JD, et al. Association of benign prostatic hyperplasia with male pattern baldness. Urology 1998; 51: 744-8. (Pubitemid 28261925)
4. Su LH, Chen TH,. Association of androgenetic alopecia with metabolic syndrome in men: a community-based survey. Br J Dermatol 2010; 163: 371-7.
5. Randall VA,. Androgens and hair growth. Dermatol Ther 2008; 21: 314-28.
6. Goh C, Zippin JH,. Androgenetic alopecia: diagnosis and treatment with a focus on recent genetic implications. J Drugs Dermatol 2009; 8: 185-92.
7. Hoffman RM,. Gene and stem cell therapy of the hair follicle. Methods Mol Biol 2005; 289: 437-48.
8. Jandali S, Low DW,. From surgery to pharmacology to gene therapy: the past, present, and future of hair restoration. Ann Plast Surg 2010; 65: 437-42.
9. Jensen TG,. Cutaneous gene therapy. Ann Med 2007; 39: 108-15. (Pubitemid 46598178)
10. Ohyama M, Vogel JC,. Gene delivery to the hair follicle. J Investig Dermatol Symp Proc 2003; 8: 204-6. (Pubitemid 37222831)
11. Dugour A, Hagelin K, Smus C, et al. Silencing the androgen receptor: new skills for antiandrogen oligonucleotide skin and hair therapy. J Dermatol Sci 2009; 54: 123-5.
12. Ambros V,. The functions of animal microRNAs. Nature 2004; 431: 350-5. (Pubitemid 39265675)
13. Soifer HS, Rossi JJ, Saetrom P,. MicroRNAs in disease and potential therapeutic applications. Mol Ther 2007; 15: 2070-9. (Pubitemid 350148921)
14. Lewis BP, Burge CB, Bartel DP,. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120: 15-20. (Pubitemid 40094598)
15. Williams AE,. Functional aspects of animal microRNAs. Cell Mol Life Sci 2008; 65: 545-62. (Pubitemid 351297689)
16. Erson AE, Petty EM,. MicroRNAs in development and disease. Clin Genet 2008; 74: 296-306.
17. Medina PP, Slack FJ,. MicroRNAs and cancer: an overview. Cell Cycle 2008; 7: 2485-92.
18. Sand M, Gambichler T, Sand D, et al. MicroRNAs and the skin: tiny players in the body's largest organ. J Dermatol Sci 2009; 53: 169-75.
19. Xu G, Wu J, Zhou L, et al. Characterization of the small RNA transcriptomes of androgen dependent and independent prostate cancer cell line by deep sequencing. PLoS ONE 2010; 5: e15519.
20. Narayanan R, Jiang J, Gusev Y, et al. MicroRNAs are mediators of androgen action in prostate and muscle. PLoS ONE 2010; 5: e13637.
21. Goodarzi HR, Abbasi A, Saffari M, et al. MicroRNAs take part in pathophysiology and pathogenesis of male pattern baldness. Mol Biol Rep 2010; 37: 2959-65.
22. Magerl M, Kauser S, Paus R, et al. Simple and rapid method to isolate and culture follicular papillae from human scalp hair follicles. Exp Dermatol 2002; 11: 381-5. (Pubitemid 36934671)
23. Takada S, Mano H,. Profiling of microRNA expression by mRAP. Nat Protoc 2007; 2: 3136-45.
24. Chen C, Ridzon DA, Broomer AJ, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005; 33: e179.
25. Mestdagh P, Feys T, Bernard N, et al. High-throughput stem-loop RT-qPCR miRNA expression profiling using minute amounts of input RNA. Nucleic Acids Res 2008; 36: e143.
26. Ruijter JM, Ramakers C, Hoogaars WM, et al. Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data. Nucleic Acids Res 2009; 37: e45.
27. Audic S, Claverie JM,. The significance of digital gene expression profiles. Genome Res 1997; 7: 986-95. (Pubitemid 27487763)
28. Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 2006; 103: 2257-61. (Pubitemid 43271657)
29. Ambs S, Prueitt RL, Yi M, et al. Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. Cancer Res 2008; 68: 6162-70.
30. Galardi S, Mercatelli N, Giorda E, et al. miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. J Biol Chem 2007; 282: 23716-24. (Pubitemid 47311902)
31. Porkka KP, Pfeiffer MJ, Waltering KK, et al. microRNA expression profiling in prostate cancer. Cancer Res 2007; 67: 6130-5. (Pubitemid 47037493)
32. Spahn M, Kneitz S, Scholz CJ, et al. Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence. Int J Cancer 2010; 127: 394-403.
33. Sun T, Wang Q, Balk S, et al. The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer cell lines. Cancer Res 2009; 69: 3356-63.
34. Tong AW, Fulgham P, Jay C, et al. MicroRNA profile analysis of human prostate cancers. Cancer Gene Ther 2009; 16: 206-16.
35. Fornari F, Gramantieri L, Ferracin M, et al. MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. Oncogene 2008; 27: 5651-61.
36. Randall VA, Jenner TJ, Hibberts NA, et al. Stem cell factor/c-Kit signalling in normal and androgenetic alopecia hair follicles. J Endocrinol 2008; 197: 11-23. (Pubitemid 351566921)
37. Felli N, Fontana L, Pelosi E, et al. MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc Natl Acad Sci USA 2005; 102: 18081-6. (Pubitemid 41798505)
38. Lee YS, Kim HK, Chung S, et al. Depletion of human micro-RNA miR-125b reveals that it is critical for the proliferation of differentiated cells but not for the down-regulation of putative targets during differentiation. J Biol Chem 2005; 280: 16635-41. (Pubitemid 41389120)
39. Shi XB, Xue L, Yang J, et al. An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells. Proc Natl Acad Sci USA 2007; 104: 19983-8.
40. Ozen M, Creighton CJ, Ozdemir M, et al. Widespread deregulation of microRNA expression in human prostate cancer. Oncogene 2008; 27: 1788-93. (Pubitemid 351380263)
41. Bloomston M, Frankel WL, Petrocca F, et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 2007; 297: 1901-8. (Pubitemid 46707844)
42. Nelson PT, Baldwin DA, Kloosterman WP, et al. RAKE and LNA-ISH reveal microRNA expression and localization in archival human brain. RNA 2006; 12: 187-91. (Pubitemid 43121922)
43. Visone R, Pallante P, Vecchione A, et al. Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. Oncogene 2007; 26: 7590-5. (Pubitemid 350207711)
44. Hibberts NA, Howell AE, Randall VA,. Balding hair follicle dermal papilla cells contain higher levels of androgen receptors than those from non-balding scalp. J Endocrinol 1998; 156: 59-65. (Pubitemid 28049864)
45. Scott GK, Goga A, Bhaumik D, et al. Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b. J Biol Chem 2007; 282: 1479-86. (Pubitemid 47076526)
46. Olive V, Jiang I, He L,. miR-17-92, a cluster of miRNAs in the midst of the cancer network. Int J Biochem Cell Biol 2010; 42: 1348-54.
47. He L, Thomson JM, Hemann MT, et al. A microRNA polycistron as a potential human oncogene. Nature 2005; 435: 828-33. (Pubitemid 40839734)
48. Landais S, Landry S, Legault P, et al. Oncogenic potential of the miR-106-363 cluster and its implication in human T-cell leukemia. Cancer Res 2007; 67: 5699-707. (Pubitemid 46985002)
49. Li Y, Tan W, Neo TW, et al. Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma. Cancer Sci 2009; 100: 1234-42.
50. Ivanovska I, Ball AS, Diaz RL, et al. MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression. Mol Cell Biol 2008; 28: 2167-74. (Pubitemid 351429964)